🔗 Share this article

Chancellor Reeves has revealed she is planning "targeted steps to address household expense challenges" in the upcoming Budget.

During an interview with media outlets, she emphasized that reducing price rises is a joint responsibility of both the administration and the Bank of England.

The United Kingdom's price growth is forecast to be the most elevated among the G7 advanced economies this calendar year and the following year.

Possible Energy Bill Measures

Sources suggest the government could intervene to lower utility costs, for instance by cutting the present 5% level of VAT charged on energy supplies.

Another approach is to cut some of the government charges currently included in bills.

Fiscal Constraints and Analyst Expectations

The administration will obtain the next assessment from the official forecaster, the OBR, on the start of the week, which will show how much room there is for these actions.

The consensus from the majority of economists is that the Chancellor will have to declare higher taxes or spending cuts in order to meet her voluntary debt limits.

Previously on the same day, analysis suggested there was a £22bn gap for the chancellor to resolve, which is at the lower end of expectations.

"It is a joint job between the central bank and the government to bear down further on some of the sources of inflation," the Chancellor told the BBC in the US capital, at the conferences of the IMF and global financial institution.

Tax Commitments and International Concerns

While a great deal of the focus has been on probable tax increases, the Treasury chief said the latest figures from the OBR had not changed her pledge to election pledges not to raise rates on earnings tax, VAT or National Insurance.

She blamed an "unpredictable world" with increasing geopolitical and commercial concerns for the Budget revenue measures, probably to be directed on those "wealthiest."

Global Trade Tensions

Commenting on apprehensions about the United Kingdom's economic relations with China she said: "Our security interests invariably take priority."

Recent announcement by Chinese authorities to increase export controls on critical minerals and other materials that are key for high-technology production led US President Donald Trump to threaten an additional 100% tariff on imports from China, raising the risk of an full-scale commercial conflict between the two economic giants.

The American finance chief described the Chinese action "commercial pressure" and "a global supply chain control attempt."

Questioned on considering the US offer to join its battle with China, Reeves said she was "very concerned" by Chinese measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the move was "bad for the global economy and generates additional challenges."

"It is my opinion there are fields where we need to address Chinese policies, but there are also important chances to sell into China's economy, including financial services and other sectors of the economy. We've got to achieve that equilibrium appropriate."

The Treasury chief also confirmed she was working with international partners "regarding our own essential resources strategy, so that we are less reliant."

Health Service Drug Pricing and Investment

The Chancellor also acknowledged that the cost the National Health Service spends on pharmaceuticals could rise as a consequence of ongoing talks with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or abandoning operations in the UK, with several attributing the insufficient payments they are obtaining.

Recently, the Science Minister said the price the health service spends on drugs would have to go up to stop businesses and pharmaceutical investment departing from the UK.

The Chancellor stated to media: "It has been observed because of the cost structure, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the extent that they are in other continental states."

"The objective is to ensure that individuals receiving treatment from the NHS are can obtain the top critical medicines in the world. And so we are reviewing this situation, and... seeking to secure more capital into Britain."